9999999997-17-008182.txt : 20170822 9999999997-17-008182.hdr.sgml : 20170822 20170822130948 ACCESSION NUMBER: 9999999997-17-008182 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170822 DATE AS OF CHANGE: 20170822 ACTION DATE: 20170822 RECEIVED DATE: 20170822 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Juno Therapeutics, Inc. CENTRAL INDEX KEY: 0001594864 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 463656275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-36781 FILM NUMBER: 171044682 BUSINESS ADDRESS: STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 2065821600 MAIL ADDRESS: STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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